2025-520929-20-00招募中3 期
MULTICENTER, DOUBLE BLIND CLINICAL TRIAL TO EVALUATE THE ANTIHEMORRAGIC EFFECT OF THE TOPICAL TRANEXAMIC ACID DURING PACEMAKER IN ANTICOAGULATED PATIENTS
Hospital Universitario Tajo3 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年1月30日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 100
- 试验地点
- 3
- 主要终点
- Evaluation of hemorrhage and/or hematoma in patients anticoagulated with acenocoumarol after pacemaker implantation and the effect of tranexamic acid (TXA) to reduce these events.
研究概览
简要总结
Evaluation of hemorrhage and/or hematoma in patients anticoagulated with acenocoumarol after pacemaker implantation and the effect of tranexamic acid (TXA) to reduce these events.
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 否
入选标准
- •All patients undergoing permanent pacemaker implantation, over 18 years of age, who give their consent and who receive anticoagulant therapy with acenocoumarol prior to the procedure.
排除标准
- •Minors under 18 years of age • Use of antiplatelet agent other than ASA in the 5 days prior to implantation • INR >3.5 or INR <2 • Denial of informed consent
结局指标
主要结局
Evaluation of hemorrhage and/or hematoma in patients anticoagulated with acenocoumarol after pacemaker implantation and the effect of tranexamic acid (TXA) to reduce these events.
Evaluation of hemorrhage and/or hematoma in patients anticoagulated with acenocoumarol after pacemaker implantation and the effect of tranexamic acid (TXA) to reduce these events.
次要结局
- Assess the occurrence of the following events: • Infectious complications • Duration of the procedure • Hospital stay • Need for blood products • Need for prohemostatic drugs • Thrombotic complications
研究者
Rafael Blancas-Casero
Scientific
Hospital Universitario Tajo
研究点 (3)
Loading locations...
相似试验
招募中
3 期
Blood thinners after transcatheter implantation of a new heart valve in patients with aortic stenosisAortic stenosis2023-510211-20-00Oslo University Hospital HF360
招募中
2 期
Platelet inhibition versus direct oral anticoagulation in patients undergoing percutaneous closure of patent foramen ovale or atrial septal defect2024-517115-70-00Sint Antonius Ziekenhuis Stichting52
招募中
3 期
Safety and efficacy of apixaban versus warfarin in peritoneal dialysis patients with non valvular atrial fibrillation: a randomized controlled trial2023-507544-37-00Centre Hospitalier Universitaire De Caen Normandie178
招募中
3 期
A study to determine the effectiveness, safety, and tolerability of the Recombinant Von Willebrand Factor administered with or without Advate for children diagnosed with Severe von Willebrand Disease who experience bleeding episodes and/or will undergo major, minor or oral surgery procedures.2023-509769-18-00Baxalta Innovations GmbH8
招募中
不适用
Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic MalignanciesLymphomaLeukemiaNCT07270263Medical University of Gdansk100